Dr. Dale Bredesen identifies the defining characteristics of Alzheimer’s disease and enumerates its known subtypes.
Dr. Jed Fahey describes the chemical reaction that produces isothiocyanates and the time frame required for full conversion.
In this clip, Dr. Mark Mattson discusses the pros and cons of calorie restriction mimetics.
Dr. Rhonda Patrick and Dr. Valter Longo discuss how IGF-1 is involved in the regenerative aspect of the two phases of fasting and refeeding.
Dr. Eric Verdin describes the liver's functions and proposes that the ketogenic diet does not put any undue stress on the liver.
In this clip, Dr. Satchin Panda describes how shift work and modern lifestyles affect circadian rhythms and damage metabolic health and discusses approaches that might benefit those who work shifts.
In this clip, Dr. Steve Horvath describes research suggesting that caloric restriction, especially when it is reversing obesity or metabolic syndrome, may slow epigenetic aging.
In this clip, Dr. Rhonda Patrick describes what Mendelian randomization studies are and how they are valuable instruments in the scientific toolbox.
In this clip, Dr. Giselle Petzinger discusses how adding a cognitive load to an exercise program is important for people with Parkinson's disease.
In this clip, Dr. Axel Montagne discusses the importance of maintaining the blood-brain barrier's integrity, especially for people with the APOE4 gene who have a higher risk of developing Alzheimer's disease.
In this clip, Dr. Stuart Phillips discusses the implications of hormones in muscle mass growth and compares physiological to supraphysiological doses.
In this clip, Drs. Levine and Patrick discuss definitions of aging used in science and why biological aging matters to scientists.
Dr. Jed Fahey describes a study that demonstrated sulforaphane's chemoprotective qualities against benzene exposure.
In this clip, Dr. Eran Elinav discusses the intestinal barrier's important role in absorbing nutrients while keeping out pathogens.
Dr. Charles Raison discusses how psychedelic substances like psilocybin, which induce transcendent trance-like states may be useful in the treatment of depression.
